© Анна Ковальчук – stock.adobe.com

News • Retinal functional impairments as biomarkers

Eye exam shows potential for early detection of Parkinson's disease

Could it be possible to diagnose Parkinson's disease with the help of a simple retinal exam? The idea should be seriously considered, according to a new study.

The study was published in the journal Neurobiology of Disease by researchers from Université Laval who discovered that the retina of people with Parkinson's disease responds differently to light stimuli than that of healthy people. 

Parkinson's disease is usually diagnosed when a person consults a doctor because of motor problems such as tremors. “By then, the disease has been present for several years and the affected neurons are already engaged in an irreversible degenerative process. That's why it's important to find biomarkers that detect Parkinson's at an early stage of the disease”, explains study leader Martin Lévesque, professor at Université Laval's Faculty of Medicine and researcher at CERVO Brain Research Centre in Québec City. “The retina is a direct extension of the central nervous system and, consequently, offers a non-invasive way of exploring the brain”, continues the researcher. “An unusual response of the retina to light stimuli could be indicative of a pathology affecting the brain.”

This approach could also be used to monitor the progression of the disease, as well as the effectiveness of interventions offered to patients

Martin Lévesque

To explore this avenue, his research team recruited 20 people who had been diagnosed with Parkinson's for less than 5 years. “We placed an electrode on each participant's lower eyelid and recorded their retinal response to a series of flashes of different intensity, frequency and color. We did the same with people of the same age, but in good health. The results we obtained for people with Parkinson's had a distinct signature from those in the control group,” explains Professor Lévesque. 

The research team carried out similar tests in transgenic mice overexpressing a human protein associated with Parkinson's disease. “We used young mice in which no motor signs of the disease were yet observable. Once again, we obtained different responses in Parkinson's model animals. This suggests that the functional manifestations of Parkinson's could be detected at an early stage of the disease by retinal examination”, sums up Martin Lévesque. 

Parkinson's disease occurs most often in people over the age of 60. “We could offer a functional retinal exam from the age of 50,” continues Lévesque. “By detecting the disease early, we could offer interventions that prevent the degeneration of the neurons involved in Parkinson’s. This approach could also be used to monitor the progression of the disease, as well as the effectiveness of interventions offered to patients.” 

The study’s first author is doctoral student Victoria Soto Linan. The coauthors are Véronique Rioux, Modesto Peralta III, Nicolas Dupré, Marc Hébert and Martin Lévesque. 


Source: Université Laval

06.05.2025

Related articles

Photo

News • Chronic neurological disorder

Researchers identify early signs of Parkinson's in the blood

Researchers report on decisive steps towards an early diagnosis of Parkinson’s disease: a newly discovered biomarker in the blood could open a window of opportunity for future treatment.

Photo

News • Polygenic risk assessment

Sleep study for early detection of Alzheimer's risk

New research suggests that subtle markers during sleep – such as nocturnal micro-awakenings – may yield early clues to a greater genetic risk of developing Alzheimer’s disease.

Photo

News • Biomarker panel

Seven proteins could lead to better blood tests for Alzheimer’s

More biomarkers for better insights on Alzheimer's disease: a new study explores how a panel of seven proteins could help predict disease progression and inform more accurate treatment choices.

Subscribe to Newsletter